ENVB logo

Enveric Biosciences (ENVB) Total Assets

ENVB Annual Total Assets

$4.30 M
-$15.25 M-78.01%

31 December 2023

ENVB Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENVB Quarterly Total Assets

$4.79 M
-$1.26 M-20.84%

30 September 2024

ENVB Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENVB Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-78.0%-27.6%
3 y3 years+5.0%-69.8%
5 y5 years-85.5%-69.8%

ENVB Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-83.9%at low-85.1%+11.4%
5 y5-year-83.9%+5.0%-93.1%+16.9%
alltimeall time-91.8%>+9999.0%-93.1%>+9999.0%

Enveric Biosciences Total Assets History

DateAnnualQuarterly
Sept 2024
-
$4.79 M(-20.8%)
June 2024
-
$6.05 M(-31.6%)
Mar 2024
-
$8.85 M(+105.8%)
Dec 2023
$4.30 M(-78.0%)
$4.30 M(-35.0%)
Sept 2023
-
$6.62 M(-32.5%)
June 2023
-
$9.80 M(-38.2%)
Mar 2023
-
$15.85 M(-18.9%)
Dec 2022
$19.55 M(-26.8%)
$19.55 M(-36.6%)
Sept 2022
-
$30.86 M(+8.0%)
June 2022
-
$28.57 M(-11.2%)
Mar 2022
-
$32.18 M(+20.4%)
Dec 2021
$26.72 M(+552.2%)
$26.72 M(-61.7%)
Sept 2021
-
$69.76 M(+194.4%)
June 2021
-
$23.70 M(-8.1%)
Mar 2021
-
$25.79 M(+529.4%)
Dec 2020
$4.10 M(-83.6%)
$4.10 M(-85.4%)
Sept 2020
-
$27.99 M(+1.8%)
June 2020
-
$27.51 M(+1.4%)
Mar 2020
-
$27.14 M(+8.5%)
Dec 2019
$25.01 M(-15.6%)
$25.01 M(-6.2%)
Sept 2019
-
$26.66 M(-9.6%)
June 2019
-
$29.48 M(-3.4%)
Mar 2019
-
$30.51 M(+2.9%)
Dec 2018
$29.64 M(-43.2%)
$29.64 M(-35.4%)
Sept 2018
-
$45.90 M(+0.8%)
June 2018
-
$45.54 M(-5.0%)
Mar 2018
-
$47.92 M(-8.2%)
Dec 2017
$52.20 M(+32.1%)
$52.20 M(+10.7%)
Sept 2017
-
$47.14 M(-0.3%)
June 2017
-
$47.29 M(-4.8%)
Mar 2017
-
$49.68 M(+25.7%)
Dec 2016
$39.51 M(+185.6%)
$39.51 M(+3.6%)
Sept 2016
-
$38.12 M(+151.7%)
June 2016
-
$15.14 M(+19.9%)
Mar 2016
-
$12.63 M(-40.4%)
Dec 2015
$13.83 M(>+9900.0%)
-
Sept 2015
-
$21.21 M(+103.2%)
June 2015
-
$10.44 M(>+9900.0%)
Mar 2015
-
$3900.00(-23.5%)
Dec 2014
$5100.00(+13.3%)
$5100.00(-44.0%)
Sept 2014
-
$9100.00(-24.2%)
June 2014
-
$12.00 K(-55.1%)
Mar 2014
-
$26.70 K(+493.3%)
Dec 2013
$4500.00(-19.6%)
$4500.00(-8.2%)
Sept 2013
-
$4900.00(-25.8%)
June 2013
-
$6600.00(+22.2%)
Mar 2013
-
$5400.00(-3.6%)
Dec 2012
$5600.00(-75.1%)
$5600.00(-12.5%)
Sept 2012
-
$6400.00(0.0%)
June 2012
-
$6400.00(-37.9%)
Mar 2012
-
$10.30 K(-54.2%)
Dec 2011
$22.50 K(+1945.5%)
$22.50 K(-7.8%)
Sept 2011
-
$24.40 K(+201.2%)
June 2011
-
$8100.00(+24.6%)
Mar 2011
-
$6500.00(+490.9%)
Dec 2010
$1100.00
$1100.00(-73.8%)
Sept 2010
-
$4200.00(+35.5%)
June 2010
-
$3100.00(-67.7%)
DateAnnualQuarterly
Mar 2010
-
$9600.00(+433.3%)
Dec 2009
$1800.00(-97.4%)
$1800.00(-96.1%)
Sept 2009
-
$46.20 K(+223.1%)
June 2009
-
$14.30 K(-60.1%)
Mar 2009
-
$35.80 K(-48.6%)
Dec 2008
$69.70 K(-95.7%)
$69.70 K(-22.7%)
Sept 2008
-
$90.20 K(-8.3%)
June 2008
-
$98.40 K(-93.6%)
Mar 2008
-
$1.53 M(-4.4%)
Dec 2007
$1.60 M(+246.2%)
$1.60 M(-2.8%)
Sept 2007
-
$1.65 M(+49.8%)
June 2007
-
$1.10 M(+17.1%)
Mar 2007
-
$941.90 K(+103.2%)
Dec 2006
$463.60 K(-48.3%)
$463.60 K(-12.9%)
Sept 2006
-
$532.50 K(-10.6%)
June 2006
-
$595.90 K(-2.5%)
Mar 2006
-
$611.20 K(-31.9%)
Dec 2005
$896.90 K(-38.7%)
$896.90 K(-16.0%)
Sept 2005
-
$1.07 M(-7.1%)
June 2005
-
$1.15 M(-9.0%)
Mar 2005
-
$1.26 M(-13.7%)
Dec 2004
$1.46 M(+21.5%)
$1.46 M(+2.8%)
Sept 2004
-
$1.42 M(+43.7%)
June 2004
-
$991.70 K(-6.8%)
Mar 2004
-
$1.06 M(-11.7%)
Dec 2003
$1.21 M(-31.0%)
$1.21 M(-9.1%)
Sept 2003
-
$1.33 M(-6.3%)
June 2003
-
$1.41 M(-12.2%)
Mar 2003
-
$1.61 M(-7.8%)
Dec 2002
$1.75 M(-0.4%)
$1.75 M(-2.7%)
Sept 2002
-
$1.79 M(-0.6%)
June 2002
-
$1.80 M(+3.7%)
Mar 2002
-
$1.74 M(-0.8%)
Dec 2001
$1.75 M(-28.6%)
$1.75 M(+0.6%)
Sept 2001
-
$1.74 M(-11.8%)
June 2001
-
$1.98 M(-15.9%)
Mar 2001
-
$2.35 M(-4.4%)
Dec 2000
$2.46 M(+16.0%)
$2.46 M(-3.4%)
Sept 2000
-
$2.54 M(+4.5%)
June 2000
-
$2.43 M(-4.2%)
Mar 2000
-
$2.54 M(+184.2%)
Dec 1999
$2.12 M(+137.0%)
-
Dec 1998
$893.50 K(-71.8%)
$893.50 K(-68.1%)
Sept 1998
-
$2.80 M(-22.2%)
June 1998
-
$3.60 M(+38.5%)
Mar 1998
-
$2.60 M(-17.9%)
Dec 1997
$3.17 M(-23.6%)
$3.17 M(-1.1%)
Sept 1997
-
$3.20 M(-13.5%)
June 1997
-
$3.70 M(-24.5%)
Mar 1997
-
$4.90 M(+18.3%)
Dec 1996
$4.14 M(-5.9%)
$4.14 M(-20.4%)
Sept 1996
-
$5.20 M(-17.5%)
June 1996
-
$6.30 M(+70.3%)
Mar 1996
-
$3.70 M(-15.9%)
Dec 1995
$4.40 M(+91.3%)
$4.40 M(+63.0%)
Dec 1994
$2.30 M(-14.8%)
-
Aug 1994
-
$2.70 M
Aug 1994
$2.70 M
-

FAQ

  • What is Enveric Biosciences annual total assets?
  • What is the all time high annual total assets for Enveric Biosciences?
  • What is Enveric Biosciences annual total assets year-on-year change?
  • What is Enveric Biosciences quarterly total assets?
  • What is the all time high quarterly total assets for Enveric Biosciences?
  • What is Enveric Biosciences quarterly total assets year-on-year change?

What is Enveric Biosciences annual total assets?

The current annual total assets of ENVB is $4.30 M

What is the all time high annual total assets for Enveric Biosciences?

Enveric Biosciences all-time high annual total assets is $52.20 M

What is Enveric Biosciences annual total assets year-on-year change?

Over the past year, ENVB annual total assets has changed by -$15.25 M (-78.01%)

What is Enveric Biosciences quarterly total assets?

The current quarterly total assets of ENVB is $4.79 M

What is the all time high quarterly total assets for Enveric Biosciences?

Enveric Biosciences all-time high quarterly total assets is $69.76 M

What is Enveric Biosciences quarterly total assets year-on-year change?

Over the past year, ENVB quarterly total assets has changed by -$1.83 M (-27.63%)